New Light on Endometrial Thickness as a Risk Factor of Cancer: What Do Clinicians Need to Know?

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi:10.1002/ijc.31937
   PubMed Web of Science ®Google Scholar
• Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12–39.
   PubMed Web of Science ®Google Scholar
• Soliman PT, Oh JC, Schmeler KM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105(3):575–580. doi:10.1097/01.AOG.0000154151.14516.f7
   PubMed Web of Science ®Google Scholar
• Pennant ME, Mehta R, Moody P, et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG. 2017;124(3):404–411. doi:10.1111/1471-0528.14385
   PubMed Web of Science ®Google Scholar
• Epstein E, Fischerova D, Valentin L, et al. Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study. Ultrasound Obstet Gynecol. 2018;51(6):818–828. doi:10.1002/uog.18909
   PubMed Web of Science ®Google Scholar
• Epstein E, Blomqvist L. Imaging in endometrial cancer. Best Pract Res Clin Obstet Gynaecol. 2014;28(5):721–739. doi:10.1016/j.bpobgyn.2014.04.007
   PubMed Web of Science ®Google Scholar
• Singh S, Best C, Dunn S, Leyland N, Wolfman WL. No. 292-abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can. 2018;40(5):e391–e415. doi:10.1016/j.jogc.2018.03.007
   PubMed Web of Science ®Google Scholar
• Fischerova D, Cibula D. Ultrasound in gynecological cancer: is it time for re-evaluation of its uses? Curr Oncol Rep. 2015;17(6):28. doi:10.1007/s11912-015-0449-x
   PubMed Web of Science ®Google Scholar
• Getpook C, Wattanakumtornkul S. Endometrial thickness screening in premenopausal women with abnormal uterine bleeding. J Obstet Gynaecol Res. 2006;32(6):588–592. doi:10.1111/j.1447-0756.2006.00455.x
   PubMed Web of Science ®Google Scholar
• Ozdemir S, Celik C, Gezginç K, Kıreşi D, Esen H. Evaluation of endometrial thickness with transvaginal ultrasonography and histopathology in premenopausal women with abnormal vaginal bleeding. Arch Gynecol Obstet. 2010;282(4):395–399. doi:10.1007/s00404-009-1290-y
   PubMed Web of Science ®Google Scholar
• Bakos O, Heimer G. Transvaginal ultrasonographic evaluation of the endometrium related to the histological findings in pre- and perimenopausal women. Gynecol Obstet Invest. 1998;45(3):199–204. doi:10.1159/000009956
   PubMed Web of Science ®Google Scholar
• Minagawa Y, Sato S, Ito M, Onohara Y, Nakamoto S, Kigawa J. Transvaginal ultrasonography and endometrial cytology as a diagnostic schema for endometrial cancer. Gynecol Obstet Invest. 2005;59(3):149–154. doi:10.1159/000083089
   PubMed Web of Science ®Google Scholar
• Dueholm M, Jensen ML, Laursen H, Kracht P. Can the endometrial thickness as measured by trans-vaginal sonography be used to exclude polyps or hyperplasia in pre-menopausal patients with abnormal uterine bleeding? Acta Obstet Gynecol Scand. 2001;80(7):645–651.
   PubMed Web of Science ®Google Scholar
• Dreisler E, Poulsen LG, Antonsen SL, et al.; European Menopause and Andropause Society. EMAS clinical guide: assessment of the endometrium in peri and postmenopausal women. Maturitas. 2013;75(2):181–190. doi:10.1016/j.maturitas.2013.03.011
   PubMed Web of Science ®Google Scholar
• Kim MJ, Kim JJ, Kim SM. Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women. Obstet Gynecol Sci. 2016;59(3):192–200. doi:10.5468/ogs.2016.59.3.192
   PubMedGoogle Scholar
• Park YR, Lee SW, Kim Y, et al. Endometrial thickness cut-off value by transvaginal ultrasonography for screening of endometrial pathology in premenopausal and postmenopausal women. Obstet Gynecol Sci. 2019;62(6):445–453. doi:10.5468/ogs.2019.62.6.445
   PubMedGoogle Scholar
• Committee on Practice Bulletins—Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012;120(1):197–206. doi:10.1097/AOG.0b013e318262e320
   PubMedGoogle Scholar
• Sladkevicius P, Installé A, Van Den Bosch T, et al. International Endometrial Tumor Analysis (IETA) terminology in women with postmenopausal bleeding and sonographic endometrial thickness ≥ 4.5 mm: agreement and reliability study. Ultrasound Obstet Gynecol. 2018;51(2):259–268. doi:10.1002/uog.18813
   PubMed Web of Science ®Google Scholar
• Breijer MC, Peeters JA, Opmeer BC, et al. Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2012;40(6):621–629. doi:10.1002/uog.12306
   PubMed Web of Science ®Google Scholar
• Varner RE, Sparks JM, Cameron CD, Roberts LL, Soong SJ. Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol. 1991;78:195–199.
   PubMed Web of Science ®Google Scholar
• Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA. 1998;280:1510–1517. doi:10.1001/jama.280.17.1510
   PubMed Web of Science ®Google Scholar
• Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultra-sonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand. 2002;81:799–816. doi:10.1034/j.1600-0412.2001.810902.x
   PubMed Web of Science ®Google Scholar
• Tabor A, Watt HC, Wald NJ. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol. 2002;99:663–670. doi:10.1016/s0029-7844(01)01771-9
   PubMed Web of Science ®Google Scholar
• Timmermans A, Opmeer BC, Khan KS, et al. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol. 2010;116(1):160–167. doi:10.1097/AOG.0b013e3181e3e7e8
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG committee opinion, No. 734: the role of transvaginal ultrasonography in evaluating the endometrium of women with postmenopausal bleeding. Obstet Gynecol. 2018;131:e124–e129. doi:10.1097/AOG.0000000000002631
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Endometrial cancer. Practice Bulletin No. 149. Obstet Gynecol. 2015;125:1006–1026. doi:10.1097/01.AOG.0000462977.61229.de
   PubMedGoogle Scholar
• Wong AS, Lao TT, Cheung CW, et al. Reappraisal of endometrial thickness for the detection of endometrial cancer in postmenopausal bleeding: a retrospective cohort study. BJOG. 2016;123:439–446. doi:10.1111/1471-0528.13342
   PubMed Web of Science ®Google Scholar
• Wang J, Wieslander C, Hansen G, Cass I, Vasilev S, Holschneider CH. Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers. Gynecol Oncol. 2006;101:120–125. doi:10.1016/j.ygyno.2005.09.042
   PubMed Web of Science ®Google Scholar
• Saccardi C, Vitagliano A, Marchetti M, et al. Endometrial cancer risk prediction according to indication of diagnostic hysteroscopy in post-menopausal women. Diagnostics. 2020;10(5):257. doi:10.3390/diagnostics10050257
   Web of Science ®Google Scholar
• Long B, Clarke MA, Morillo ADM, Wentzensen N, Bakkum-Gamez JN. Ultrasound detection of endometrial cancer in women with postmenopausal bleeding: systematic review and meta-analysis. Gynecol Oncol. 2020;157(3):624–633. doi:10.1016/j.ygyno.2020.01.032
   PubMed Web of Science ®Google Scholar
• Timmerman D, Verguts J, Konstantinovic ML, et al. The pedicle artery sign based on sonography with color Doppler imaging can replace second-stage tests in women with abnormal vaginal bleeding. Ultrasound Obstet Gynecol. 2003;22:166–171. doi:10.1002/uog.203
   PubMed Web of Science ®Google Scholar
• Opolskiene G, Sladkevicius P, Valentin L. Ultrasound assessment of endometrial morphology and vascularity to predict endometrial malignancy in women with postmenopausal bleeding and sonographic endometrial thickness ≥ 4.5 mm. Ultrasound Obstetr Gynecol. 2007;30:332–340. doi:10.1002/uog.4104
   PubMed Web of Science ®Google Scholar
• Goldstein RB, Bree RL, Benson CB, et al. Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound sponsored consensus conference statement. J Ultrasound Med. 2001;20:1025–1036. doi:10.7863/jum.2001.20.10.1025
   PubMed Web of Science ®Google Scholar
• Goldstein SR. Modern evaluation of the endometrium. Obstet Gynecol. 2010;116:168–176. doi:10.1097/AOG.0b013e3181dfd557
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Monteleone P, Ciaponi M, et al. Clinical usefulness of endometrial screening by ultrasound in asymptomatic postmenopausal women. Maturitas. 2004;48:4221–4224. doi:10.1016/j.maturitas.2003.10.006
   Web of Science ®Google Scholar
• American Cancer Society. Cancer Facts & Figures 2009. Atlanta, GA: American Cancer Society; 2009.
   Google Scholar
• Smith-Bindman R, Weiss E, Feldstein V. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Ultrasound Obstet Gynecol. 2004;24:558. doi:10.1002/uog.1704
   PubMed Web of Science ®Google Scholar
• Wolfman W. No. 249-asymptomatic endometrial thickening. J Obstet Gynaecol Can. 2018;40:367–e377. doi:10.1016/j.jogc.2018.03.005
   PubMed Web of Science ®Google Scholar
• Linkov F, Edwards R, Balk J, et al. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. Eur J Cancer. 2008;44:1632–1644. doi:10.1016/j.ejca.2008.05.001
   PubMed Web of Science ®Google Scholar
• Alcázar JL, Bonilla L, Marucco J, et al. A risk of endometrial cancer and endometrial hyperplasia with atypia in asymptomatic postmenopausal women with endometrial thickness ≥11 mm: a systematic review and meta-analysis. J Clin Ultrasound. 2018;46(9):565–570. doi:10.1002/jcu.22631
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Hatti A, Tirumuru SS, Nair SS. Management of asymptomatic postmenopausal women referred to outpatient hysteroscopy service with incidental finding of thickened endometrium - a UK district general hospital experience. J Minim Invasive Gynecol. 2021;28(10):1725–1729. doi:10.1016/j.jmig.2021.02.012
   PubMed Web of Science ®Google Scholar
• Goldstein SR, Khafaga A. Ability to successfully image the endometrial echo on transvaginal ultrasound in asymptomatic postmenopausal women. Ultrasound Obstet Gynecol. 2021;58:625–629. doi:10.1002/uog.23667
   PubMed Web of Science ®Google Scholar
• Sit AS, Modugno F, Hill LM, Martin J, Weissfeld JL. Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure. Cancer Epidemiol Biomarkers Prev. 2004;13:1459–1465.
   PubMed Web of Science ®Google Scholar
• Ragupathy K, Cawley N, Ridout A, Iqbal P, Alloub M. Non-assessable endometrium in women with post-menopausal bleeding: to investigate or ignore. Arch Gynecol Obstet. 2013;288:375–378. doi:10.1007/s00404-013-2746-7
   PubMed Web of Science ®Google Scholar
• Kroon CD, Bock GH, Dieben SWM, Jansen FW. Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG. 2003;110:938–947. doi:10.1111/j.1471-0528.2003.02472.x
   PubMed Web of Science ®Google Scholar
• Kamel HS, Darwish AM, Mohamed SA. Comparison of transvaginal ultrasonography and vaginal sonohysterography in the detection of endometrial polyps. Acta Obstet Gynecol Scand. 2000;79:60–64.
   PubMed Web of Science ®Google Scholar
• Vroom AJ, Timmermans A, Bongers MY, van den Heuvel ER, Geomini P, van Hanegem N. Diagnostic accuracy of saline contrast sonohysterography in detecting endometrial polyps in women with postmenopausal bleeding: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019;54:28–34. doi:10.1002/uog.20229
   PubMed Web of Science ®Google Scholar
• Stock RJ, Kanbour A. Prehysterectomy curettage. Obstet Gynecol. 1975;45:537–541.
   PubMed Web of Science ®Google Scholar
• Guido RS, Kanbour-Shakir A, Rulin MC, Christopherson WA. Pipelle endometrial sampling. Sensitivity in the detection of endometrial cancer. J Reprod Med. 1995;40:553–555.
   PubMed Web of Science ®Google Scholar
• Elsanabesee D, Greenwood P. The performance of Pipelle endometrial sampling in a dedicated postmenopausal bleeding clinic. J Obstet Gynaecol. 2005;25:32–34. doi:10.1080/01443610400025390
   PubMedGoogle Scholar
• Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000;89:1765–1772. doi:10.1002/1097-0142(20001015)89:8<1765::AID-CNCR17>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Angioni S, Loddo A, Milano F, Piras B, Minerba L, Melis GB. Detection of benign intracavitary lesions in postmenopausal women with abnormal uterine bleeding: a prospective comparative study on outpatient hysteroscopy and blind biopsy. J Minim Invasive Gynecol. 2008;15:87–91. doi:10.1016/j.jmig.2007.10.014
   PubMed Web of Science ®Google Scholar
• Gebauer G, Hafner A, Siebzehnrubl E, Lang N. Role of hysteroscopy in detection and extraction of endometrial polyps: results of a prospective study. Am J Obstet Gynecol. 2001;184:59–63. doi:10.1067/mob.2001.108332
   PubMed Web of Science ®Google Scholar
• Loffer FD. The time has come to quit relying on a blind endometrial biopsy or dilation and curettage to rule out malignant endometrial changes. J Minim Invasive Gynecol. 2019;26:1207–1208. doi:10.1016/j.jmig.2019.04.011
   PubMed Web of Science ®Google Scholar
• Carugno J. Clinical management of vaginal bleeding in postmenopausal women. Climacteric. 2020;23(4):343–349. doi:10.1080/13697137.2020.1739642
   PubMed Web of Science ®Google Scholar
• Burbos N, Musonda P, Duncan TJ, Crocker SG, Nieto JJ, Morris EP. Postmenopausal vaginal bleeding in women using hormone replacement therapy. Menopause Int. 2012;18:5–9. doi:10.1258/mi.2011.011111
   PubMedGoogle Scholar
• Hänggi W, Bersinger N, Altermatt HJ, et al. Comparison of transvaginal ultrasonography and endometrial biopsy in surveillance in postmenopausal HRT users. Maturitas. 1997;27:133–143. doi:10.1016/S0378-5122(97)00037-6
   PubMed Web of Science ®Google Scholar
• Langer RD, Pierce JJ, O’Hanlan KA, et al. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Intervention Trial. N Engl J Med. 1997;337:1792–1798. doi:10.1056/NEJM199712183372502
   PubMed Web of Science ®Google Scholar
• Mossa B, Imperato F, Marziani R, et al. Hormonal replacement therapy and evaluation of intrauterine pathology in postmenopausal women: a ten-year study. Eur J Gynaecol Oncol. 2003;24:507–512.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG committee opinion. No. 336: tamoxifen and uterine cancer. Obstet Gynecol. 2006;107(6):1475–1478. doi:10.1097/00006250-200606000-00057
   PubMedGoogle Scholar
• Clarke MJ. WITHDRAWN: tamoxifen for early breast cancer. Cochrane Database Syst Rev. 2008;8(4):CD000486.
   Google Scholar
• Braithwaite RS, Chlebowski RT, Lau J, George S, Hess R, Col NF. Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med. 2003;18(11):937–947. doi:10.1046/j.1525-1497.2003.20724.x
   PubMed Web of Science ®Google Scholar
• Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst. 1994;86(7):527–537. doi:10.1093/jnci/86.7.527
   PubMed Web of Science ®Google Scholar
• Bevers TB, Armstrong DK, Arun B, et al. Breast cancer risk reduction. J Natl Compr Canc Netw. 2010;8(10):1112–1146. doi:10.6004/jnccn.2010.0083
   PubMed Web of Science ®Google Scholar
• Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–236. doi:10.3322/caac.20121
   PubMed Web of Science ®Google Scholar
• Cheng WF, Lin HH, Torng PL, Huang SC. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol. 1997;66(2):233–237. doi:10.1006/gyno.1997.4739
   PubMed Web of Science ®Google Scholar
• Chalas E, Costantino JP, Wickerham DL, et al. Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial. Am J Obstet Gynecol. 2005;192(4):1230–7; discussion 1237–9. doi:10.1016/j.ajog.2004.12.083
   PubMed Web of Science ®Google Scholar
• Achiron R, Lipitz S, Sivan E, et al. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Ultrasound Obstet Gynecol. 1995;6(2):116–120. doi:10.1046/j.1469-0705.1995.06020116.x
   PubMed Web of Science ®Google Scholar
• Goldstein SR. Unusual ultrasound appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol. 1994;170:447–451. doi:10.1016/S0002-9378(94)70209-8
   PubMed Web of Science ®Google Scholar
• Bertelli G, Venturini M, Del Mastro L, et al. Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients. Breast Cancer Res Treat. 1998;47(1):41–46. doi:10.1023/A:1005820115535
   PubMed Web of Science ®Google Scholar
• Love CD, Muir BB, Scrimgeour JB, Leonard RC, Dillon P, Dixon JM. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol. 1999;17(7):2050–2054. doi:10.1200/JCO.1999.17.7.2050
   PubMed Web of Science ®Google Scholar
• Fung MF, Reid A, Faught W, et al. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen. Gynecol Oncol. 2003;91(1):154–159. doi:10.1016/S0090-8258(03)00441-4
   PubMed Web of Science ®Google Scholar
• Berlière M, Charles A, Galant C, Donnez J. Uterine side effects of tamoxifen: a need for systematic pretreatment screening. Obstet Gynecol. 1998;91(1):40–44. doi:10.1016/S0029-7844(97)00591-7
   PubMed Web of Science ®Google Scholar
• Vosse M, Renard F, Coibion M, Neven P, Nogaret JM, Hertens D. Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring. Eur J Obstet Gynecol Reprod Biol. 2002;101(1):58–63. doi:10.1016/S0301-2115(01)00516-4
   PubMed Web of Science ®Google Scholar
• Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Tamoxifen and the endometrium (C-Gyn 12), college statement; 2015.
   Google Scholar
• Fleming CA, Heneghan HM, O’Brien D, McCartan DP, McDermott EW, Prichard RS. Meta-analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy. Br J Surg. 2018;105(9):1098–1106. doi:10.1002/bjs.10899
   PubMed Web of Science ®Google Scholar
• Parkash V, Fadare O, Tornos C, McCluggage WG. Committee Opinion No. 631: Endometrial Intraepithelial Neoplasia. Obstet Gynecol. 2015 Oct;126(4):897(Reaffirmed 2020).
   Google Scholar
• Saccardi C, Gizzo S, Patrelli TS, et al. Endometrial surveillance in tamoxifen users: role, timing and accuracy of hysteroscopic investigation: observational longitudinal cohort study. Endocr Relat Cancer. 2013;20(4):455–462. doi:10.1530/ERC-13-0020
   PubMed Web of Science ®Google Scholar
• Pérez-Medina T, Salazar FJ, San-Frutos L, et al. Hysteroscopic dynamic assessment of the endometrium in patients treated with long-term tamoxifen. J Minim Invasive Gynecol. 2011;18(3):349–354. doi:10.1016/j.jmig.2010.12.014
   PubMed Web of Science ®Google Scholar
• Garuti G, Sambruni I, Cellani F, Garzia D, Alleva P, Luerti M. Hysteroscopy and transvaginal ultrasonography in postmenopausal women with uterine bleeding. Int J Gynaecol Obstet. 1999;65(1):25–33. doi:10.1016/S0020-7292(98)00224-0
   PubMed Web of Science ®Google Scholar
• Ceci O, Bettocchi S, Nappi L, Di Venere R, Pansini MV, Di Fazio F. Comparison of hysteroscopic and hysterectomy findings to assess the diagnostic accuracy of office hysteroscopy in tamoxifen-treated patients with breast cancer. J Am Assoc Gynecol Laparosc. 2003;10(3):392–395. doi:10.1016/S1074-3804(05)60270-8
   PubMedGoogle Scholar
• Litta P, Merlin F, Saccardi C, et al. Role of hysteroscopy with endometrial biopsy to rule out endometrial cancer in postmenopausal women with abnormal uterine bleeding. Maturitas. 2005;50(2):117–123. doi:10.1016/j.maturitas.2004.05.003
   PubMed Web of Science ®Google Scholar